U04 Stock Overview
An incubator, venture capital and accelerator firm specializing in incubation and startup. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Pegasus Mercantile Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.017 |
| 52 Week High | CA$0.046 |
| 52 Week Low | CA$0.0035 |
| Beta | -0.63 |
| 11 Month Change | 135.71% |
| 3 Month Change | 17.86% |
| 1 Year Change | 83.33% |
| 33 Year Change | -90.12% |
| 5 Year Change | -88.21% |
| Change since IPO | -99.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| U04 | DE Capital Markets | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.4% | 1.1% |
| 1Y | 83.3% | 25.5% | 7.2% |
Return vs Industry: U04 exceeded the German Capital Markets industry which returned 25.5% over the past year.
Return vs Market: U04 exceeded the German Market which returned 7.2% over the past year.
Price Volatility
| U04 volatility | |
|---|---|
| U04 Average Weekly Movement | 59.4% |
| Capital Markets Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: U04's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: U04's weekly volatility has decreased from 78% to 59% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | Meris Kott | xtacytherapeutics.com |
Pegasus Mercantile Inc. is an incubator, venture capital and accelerator firm specializing in incubation and startup. The firm seeks to invest in the public and private sectors that focus on preventative health, wellness issues, related consumer products, biotechnology, specific areas of pain, Psychedelic, depression, mental illness health and medicine sectors. By investing in pioneering techniques such as micro-dosing using organic compounds and synthetic molecules, we are focussing on ground breaking research with the aim of providing superior wellness benefits with less side effects, better for peoples and the planet.
Pegasus Mercantile Inc. Fundamentals Summary
| U04 fundamental statistics | |
|---|---|
| Market cap | €1.18m |
| Earnings (TTM) | -€132.26k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-8.9x
P/E RatioIs U04 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| U04 income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$195.68k |
| Earnings | -CA$195.68k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0034 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -5.1% |
How did U04 perform over the long term?
See historical performance and comparison